A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)

Prometheus Site 26, The Bronx

Prometheus Site 22, Great Neck

Prometheus Site 33, Poughkeepsie

Prometheus Site 5, Chevy Chase

Prometheus Site 34, Charlottesville

Prometheus Site 41, Greenville

Prometheus Site 32, Kinston

Prometheus Site 43, Columbia

Prometheus Site 11, Decatur

Prometheus Site 37, Athens

Prometheus Site 36, Orlando

Prometheus Site 44, Orlando

Prometheus Site 55, Hialeah

Prometheus Site 17, Fort Lauderdale

Prometheus Site 35, Clearwater

Prometheus Site 8, Naples

Prometheus Site 13, Naples

Prometheus Site 51, Southfield

Prometheus Site 6, Chesterfield

Prometheus Site 48, Wyoming

Prometheus Site 31, Plymouth

Prometheus Site 7, Rapid City

Prometheus Site 54, Hoffman Estates

Prometheus Site 53, Chicago

Prometheus Site 40, St Louis

Prometheus Site 20, Topeka

Prometheus Site 4, Shreveport

Prometheus Site 10, Little Rock

Prometheus Site 49, Houston

Prometheus Site 39, Humble

Prometheus Site 47, San Antonio

Prometheus Site 9, San Antonio

Prometheus Site 27, Lafayette

Prometheus Site 45, Lone Tree

Prometheus Site 23, Orem

Prometheus Site 25, Salt Lake City

Prometheus Site 24, Phoenix

Prometheus Site 15, Chula Vista

Prometheus Site 30, Oceanside

Prometheus Site 28, Rialto

Prometheus Site 2, Ventura

Prometheus Site 42, Lancaster

Prometheus Site 12, Richland

Prometheus Research Site 1, Brockton

Prometheus Site 21, Lebanon